Jennifer Robblee

Dr. Jennifer Robblee, a headache neurologist at the Barrow Neurological Institute, discusses groundbreaking migraine treatments: gepants and ditans. These new medications are reshaping acute migraine management, with fewer side effects compared to traditional triptans. The conversation highlights their effectiveness, including specific examples like ubrojapant and lasmititan. Dr. Robblee emphasizes the importance of personalized treatment plans to ensure the right therapies for individual patients, paving the way for a more innovative approach to migraine relief.

Dr. Jennifer Robblee and Dr. Lawrence Robbins discuss challenges in diagnosing and managing refractory headaches, debunking misconceptions and exploring treatment options like medication combinations and alternative therapies. They also highlight the importance of further research and understanding comorbidity burden in chronic migraine patients.